Vortioxetine Clinical Trials
5 recruitingDrug
Phase 24Phase 41Phase 11
Showing 1–5 of 5 trials
Recruiting
Phase 2
Vortioxetine for Newly Diagnosed Glioblastoma
Glioblastoma
University of Zurich78 enrolled1 locationNCT07284628
Recruiting
Phase 4
RNA Editing as a Biomarker of Antidepressant Response in Unipolar and Bipolar Depression (EDIT-ANDRE)
Unipolar DepressionBipolar Depression
Mayo Clinic120 enrolled1 locationNCT07266545
Recruiting
Phase 2
Vortioxetine for the Treatment of Mood and Cognitive Symptoms in Frontotemporal Dementia
fronto-temporal dementiaFrontotemporal DementiaFrontotemporal Degeneration+3 more
Johns Hopkins University50 enrolled1 locationNCT06604520
Recruiting
Phase 1Phase 2
Sequenced Treatment Alternatives to Relieve Adolescent Depression (STAR-AD)
DepressionSequestra
First Affiliated Hospital of Chongqing Medical University520 enrolled1 locationNCT05814640
Recruiting
Phase 2
Fortifying Healthy Behaviors, Optimizing Medical Therapies and Enhancing Cognitive Function in Older Adults-pilot Study
Older AdultsCognitive DeclineAging+1 more
Washington University School of Medicine20 enrolled1 locationNCT07000734